Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

S'inscrire

MACK Merrimack Pharmaceuticals Inc

15,1575

0,00 (0,00%)

31 Mai 2024 - Fermé

Retardé de 15 minutes

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

Merrimack Pharmaceuticals (NASDAQ:MACK)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024

Plus de graphiques de la Bourse Merrimack Pharmaceuticals

Merrimack Pharmaceuticals (NASDAQ:MACK)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024

Plus de graphiques de la Bourse Merrimack Pharmaceuticals

Actualités Merrimack Pharmaceuticals Inc

Form 15-12G - Securities registration termination [Section 12(g)]
Lundi 20 Mai 2024 ( il y a 2 semaines) • Edgar (US Regulatory)

Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities
Vendredi 10 Mai 2024 ( il y a 3 semaines) • Edgar (US Regulatory)

Form 8-K - Current report
Vendredi 10 Mai 2024 ( il y a 3 semaines) • Edgar (US Regulatory)

Merrimack Pharmaceuticals, Inc. Announces Stockholder Approval of Plan of Dissolution And Cash Liquidating Dividend Amount of $15.10 Per Share of Common Stock
Vendredi 10 Mai 2024 ( il y a 3 semaines) • Business Wire

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Jeudi 9 Mai 2024 ( il y a 3 semaines) • Edgar (US Regulatory)

Form 8-K - Current report
Jeudi 9 Mai 2024 ( il y a 3 semaines) • Edgar (US Regulatory)

Merrimack Pharmaceuticals, Inc. Announces Anticipated Final Cash Dividend Amount of Initial Liquidating Distribution, Subject to Receipt of Stockholder Approval of Plan of Dissolution
Jeudi 9 Mai 2024 ( il y a 3 semaines) • Business Wire

Merrimack Pharmaceuticals Announces Notification of Plan to Voluntary Delist Common Stock on NASDAQ Subject to Receipt of Stockholder Approval of Plan of Dissolution
Mardi 30 Avril 2024 ( il y a 1 mois) • Business Wire

Merrimack Receives $225 Million Milestone Payment from Ipsen
Mercredi 27 Mars 2024 ( il y a 2 mois) • Business Wire

Form 425 - Prospectuses and communications, business combinations
Jeudi 7 Mars 2024 ( il y a 3 mois) • Edgar (US Regulatory)

Form 8-K - Current report
Jeudi 7 Mars 2024 ( il y a 3 mois) • Edgar (US Regulatory)

Merrimack Reports Full Year 2023 Financial Results
Jeudi 7 Mars 2024 ( il y a 3 mois) • Business Wire

Plus d'articles sur Merrimack Pharmaceuticals Inc

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales